147 related articles for article (PubMed ID: 17478205)
1. Health-related quality of life in hereditary hemorrhagic telangiectasia.
Geisthoff UW; Heckmann K; D'Amelio R; Grünewald S; Knöbber D; Falkai P; König J
Otolaryngol Head Neck Surg; 2007 May; 136(5):726-33; discussion 734-5. PubMed ID: 17478205
[TBL] [Abstract][Full Text] [Related]
2. [Recurrent nosebleeds in patients with hereditary hemorrhagic telangiectasia].
Slotosch D; Koller M; Werner JA; Folz BJ
Dtsch Med Wochenschr; 2006 Mar; 131(11):535-9. PubMed ID: 16538555
[TBL] [Abstract][Full Text] [Related]
3. The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia.
Lennox PA; Hitchings AE; Lund VJ; Howard DJ
Am J Rhinol; 2005; 19(1):71-4. PubMed ID: 15794078
[TBL] [Abstract][Full Text] [Related]
4. The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia.
Merlo CA; Yin LX; Hoag JB; Mitchell SE; Reh DD
Int Forum Allergy Rhinol; 2014 Nov; 4(11):921-5. PubMed ID: 25145809
[TBL] [Abstract][Full Text] [Related]
5. Altered quality of life in Rendu-Osler-Weber disease related to recurrent epistaxis.
Ingrand I; Ingrand P; Gilbert-Dussardier B; Defossez G; Jouhet V; Migeot V; Dufour X; Klossek JM
Rhinology; 2011 Jun; 49(2):155-62. PubMed ID: 21743869
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia.
Kjeldsen AD; Kjeldsen J
Am J Gastroenterol; 2000 Feb; 95(2):415-8. PubMed ID: 10685743
[TBL] [Abstract][Full Text] [Related]
7. Surviving meningococcal septic shock: health consequences and quality of life in children and their parents up to 2 years after pediatric intensive care unit discharge.
Buysse CM; Raat H; Hazelzet JA; Hop WC; Maliepaard M; Joosten KF
Crit Care Med; 2008 Feb; 36(2):596-602. PubMed ID: 18216608
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic children with hereditary hemorrhagic telangiectasia: a pediatric center experience.
Mei-Zahav M; Letarte M; Faughnan ME; Abdalla SA; Cymerman U; MacLusky IB
Arch Pediatr Adolesc Med; 2006 Jun; 160(6):596-601. PubMed ID: 16754821
[TBL] [Abstract][Full Text] [Related]
9. Evidence of small-bowel involvement in hereditary hemorrhagic telangiectasia: a capsule-endoscopic study.
Ingrosso M; Sabbà C; Pisani A; Principi M; Gallitelli M; Cirulli A; Francavilla A
Endoscopy; 2004 Dec; 36(12):1074-9. PubMed ID: 15578297
[TBL] [Abstract][Full Text] [Related]
10. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.
Fiorella ML; Ross D; Henderson KJ; White RI
Laryngoscope; 2005 Feb; 115(2):301-5. PubMed ID: 15689755
[TBL] [Abstract][Full Text] [Related]
11. Enteroscopic evaluation of the gastrointestinal tract in symptomatic patients with hereditary hemorrhagic telangiectasia.
Proctor DD; Henderson KJ; Dziura JD; Longacre AV; White RI
J Clin Gastroenterol; 2005 Feb; 39(2):115-9. PubMed ID: 15681905
[TBL] [Abstract][Full Text] [Related]
12. The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
Harvey RJ; Kanagalingam J; Lund VJ
Am J Rhinol; 2008; 22(2):182-7. PubMed ID: 18416977
[TBL] [Abstract][Full Text] [Related]
13. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study.
Salaffi F; Cimmino MA; Malavolta N; Carotti M; Di Matteo L; Scendoni P; Grassi W;
J Rheumatol; 2007 Jul; 34(7):1551-60. PubMed ID: 17516618
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT).
Zarrabeitia R; Fariñas-Álvarez C; Santibáñez M; Señaris B; Fontalba A; Botella LM; Parra JA
Health Qual Life Outcomes; 2017 Jan; 15(1):19. PubMed ID: 28114930
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of patients with hereditary hemorrhagic telangiectasia with video capsule endoscopy: a single-center prospective study.
Chamberlain SM; Patel J; Carter Balart J; Gossage JR; Sridhar S
Endoscopy; 2007 Jun; 39(6):516-20. PubMed ID: 17554646
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.
Dheyauldeen S; Østertun Geirdal A; Osnes T; Vartdal LS; Dollner R
Laryngoscope; 2012 Jun; 122(6):1210-4. PubMed ID: 22565282
[TBL] [Abstract][Full Text] [Related]
17. Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire.
Karapantzos I; Tsimpiris N; Goulis DG; Van Hoecke H; Van Cauwenberge P; Danielides V
Eur Arch Otorhinolaryngol; 2005 Oct; 262(10):830-3. PubMed ID: 15739086
[TBL] [Abstract][Full Text] [Related]
18. A grading scale for epistaxis in hereditary haemorrhagic teleangectasia.
Al-Deen S; Bachmann-Harildstad G
Rhinology; 2008 Dec; 46(4):281-4. PubMed ID: 19145996
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous embolization on hereditary hemorrhagic telangiectasia patients with severe epistaxis.
Braak SJ; de Witt CA; Disch FJ; Overtoom TT; Westermann JJ
Rhinology; 2009 Jun; 47(2):166-71. PubMed ID: 19593974
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in head and neck cancer survivors: a cross-sectional survey.
Chaukar DA; Walvekar RR; Das AK; Deshpande MS; Pai PS; Chaturvedi P; Kakade A; D'Cruz AK
Am J Otolaryngol; 2009; 30(3):176-80. PubMed ID: 19410123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
